Loading...


*  Coagulation factor II receptor - Wikipedia
Blood. 82 (5): 1532-7. PMID 8395910. "Entrez Gene: F2R coagulation factor II (thrombin) receptor". "José RJ, Williams AE, ... Proteinase-activated receptor 1 (PAR1) also known as Protease-activated receptor 1 or coagulation factor II (thrombin) receptor ... blood. 105 (8): 3178-84. doi:10.1182/blood-2004-10-3985. PMID 15626732. José RJ, Williams AE, Mercer PF, Sulikowski MG, Brown ... PAR-1 has multifaceted effects and plays a key role in mediating the interplay between coagulation and inflammation, which is ...
  https://en.wikipedia.org/wiki/Coagulation_factor_II_receptor
*  Prothrombin Complex Concentrate (Human) [(Factors II, VII, IX, X), Protein C, and Protein S] (Professional Patient Advice) -...
Factors II, VII, IX, X), Protein C, and Protein S]. Includes: pharmacology, pharmacokinetics, contraindications, interactions, ... while factor VII is part of the extrinsic coagulation pathway. In the extrinsic pathway, damaged blood vessels release ... Factor IXa (as well as TF-factor VIIa) converts factor X to factor Xa in the final common pathway of coagulation. Factor Xa ... Coagulation factor deficiency: Hepatic synthesis of the prothrombin complex (Factors II, VII, IX and X) coagulation factors is ...
  https://www.drugs.com/ppa/prothrombin-complex-concentrate-human-factors-ii-vii-ix-x-protein-c-and-protein-s.html
*  Fibrinopeptides, blood-coagulation factors or derivatives > Patents - Class: 514...
Factor VII glycoforms. Jun. 7, 2005. 6884616. DNA-construct for the tissue-specific expression of a blood coagulation factor. ... Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X. Feb. 12, 2002. ... Name: Drug, bio-affecting and body treating compositions > Fibrinopeptides, blood-coagulation factors or derivatives. ... Description: Subject matter wherein the peptide composition is related to fibrinopeptides, blood-coagulation factors or ...
  http://www.patentgenius.com/class/514/802.html
*  IJMS | Free Full-Text | Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases
... with modulatory effects or modulated by the coagulation cascade have been reported to affect the pathophysiology of the central ... being able to interfere with synaptic homeostasis other than coagulation itself. These specific functions modulate neuronal ... Blood coagulation factors and other proteins, with modulatory effects or modulated by the coagulation cascade have been ... "Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases." Int. J. Mol. Sci. 18, no. 10: 2128. ...
  http://www.mdpi.com/1422-0067/18/10/2128
*  New VCell model of blood coagulation factors - VCell- Modeling & Analysis Software
New VCell model of blood coagulation factors 2016 -06-09 Hysteresis-like binding of coagulation factors x/xa to procoagulant ...
  http://vcell.org/vcell-model-of-blood-coagulation-factors
*  Collaborative study on the 2nd International Standard for Blood Coagulation Factor XI, Plasma (‎15/180)‎: assignment of...
2016)‎. Collaborative study on the 2nd International Standard for Blood Coagulation Factor XI, Plasma (‎15/180)‎: assignment of ... Collaborative study on the 1st international standard for blood coagulation factor XII, plasma: assignment of functional (‎FXII ... Collaborative study on the 2nd International Standard for Blood Coagulation Factor XI, Plasma (‎15/180)‎: assignment of ... Collaborative study for value assignment of the 4th [‎fourth]‎ international standard for factors II, VII, IX, X, plasma / by ...
  http://apps.who.int/iris/handle/10665/253047
*  Controlled assembly of peptide-functionalized gold nanoparticles for label-free detection of blood coagulation Factor XIII...
Activated Factor XIII catalyzes the formation of covalent crosslinking between peptide chains through ε-(γ- ... A highly sensitive label-free assay for the determination of blood coagulation Factor XIII activity is demonstrated through the ... A highly sensitive label-free assay for the determination of blood coagulation Factor XIII activity is demonstrated through the ... Controlled assembly of peptide-functionalized gold nanoparticles for label-free detection of blood coagulation Factor XIII ...
  http://pubs.rsc.org/en/Content/ArticleLanding/2014/CC/C4CC00572D?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+rss%2FCC+%28RSC+-+Chem.+Commun.+latest+articles%29
*  Expression and characterization of a codonoptimized blood coagulation factor VIII - Surrey Research Insight Open Access
Expression and characterization of a codon-optimized blood coagulation factor VIII. J Thromb Haemost 2017; 15: 709-20, which ... Coagulation Factor VIII; LRP1 protein, human; von Willebrand Factor, Lentivirus; Hemophilia A ... Expression and characterization of a codonoptimized blood coagulation factor VIII Journal of Thrombosis and Haemostasis, 15 (4 ... Background: Production of recombinant factor VIII (FVIII) is challenging due to its low expression. It was previously shown ...
  http://epubs.surrey.ac.uk/813284/
*  Cardiovascular & Blood : Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis
Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis. The "Coagulation Factors 2009: Target Pipeline and ... Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis. Publisher: La Merie Publishing ×. La Merie ... The market size of recombinant and plasma-derived coagulation factor products exceeded US$ 7.5 bln in 2008, the majority (US$ ... The authors analyze and assess the target pipeline for each of the coagulation factors used for systemic and topical ...
  http://pipelinereview.com/index.php/therapeuticarea/cardiovascular/coagulation-factors-2009-target-pipeline-and-corporate-benchmar-detail
*  Design and synthesis of macrocyclic indoles targeting blood coagulation cascade Factor XIa
The synthesis of a series of novel macrocyclic compounds designed to target blood coagulation Factor XIa is described. The ... Design and synthesis of macrocyclic indoles targeting blood coagulation cascade Factor XIa. Hanessian, Stephen ... Several compounds displayed modest activity and good selectivity for Factor XIa. Within the series, a promising lead structure ...
  http://umu.diva-portal.org/smash/record.jsf?pid=diva2:372080
*  GPM.1.8.2.0003.15 Determination of blood coagulation factors activity | Pharmacopoeia.ru
GPM.1.8.2.0003.15 Determination of blood coagulation factors activity Ministry of Health of the Russian Federation General ... Coagulation factor activity testing is based on two approaches:. *One-step method. Blood coagulation recovered in factor ... Factor X * Clot-based method.. Factor X is determined using human factor X-deficient plasma as the substrate. The coagulation ... Factor VIII is assayed using a set of reagents in which factor VIII serves as a co-factor for factor IХа during activation of ...
  http://pharmacopoeia.ru/en/ofs-1-8-2-0003-15-opredelenie-aktivnosti-faktorov-svertyvaniya-krovi/
*  Cardiovascular & Blood : Coagulation Factors 2011 - who does meet the market needs? A Pipeline Assessment, Market Survey and...
3 Coagulation Factor Markets. 3.1 Recombinant Factor VIIIa Market 3.2 Recombinant Factor IXa Market 3.3 Recombinant Factor VIIa ... 5.1 Factor VIII 5.2 Factor IX 5.3 Factor VII 5.4 Alternative Procoagulants & Adjuncts 5.5 Factor XIII 5.6 von Willebrand Factor ... Coagulation Factors 3.7 Plasma-Derived Coagulation Factors. 4 Pipeline Changes since September 2010 4.1 Alnylam Pharmaceuticals ... Table 47 Pharmstandard's Coagulation Factor Pipeline Table 48 Pfizer's Coagulation Factor Pipeline Table 49 Pfizer's Strategic ...
  http://pipelinereview.com/index.php/therapeuticarea/cardiovascular/coagulation-factors-2011-who-does-meet-the-market-needs-a-pi-detail
*  Global Blood Coagulation Testing Market Growth Opportunities, Key Driven Factors, Market Scenario Fo
Global Blood Coagulation Testing Market Information by instruments (prothrombin time, APTT, thrombo test) by methods (Global ... Pune, Maharashtra -- (SBWIRE) -- 01/25/2017 -- Market Synopsis of Blood Coagulation Testing Market:. Blood Coagulation Testing ... Global Blood Coagulation Testing Market Growth Opportunities, Key Driven Factors, Market Scenario Forecast to 2027. Global ... To provide insights about factors affecting the market growth. - To Analyze the Global Blood Coagulation Testing Market based ...
  http://www.sbwire.com/press-releases/global-blood-coagulation-testing-market-growth-opportunities-key-driven-factors-market-scenario-forecast-to-2027-764331.htm
*  Whole blood platelet aggregation and coagulation factors in pa...
Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.: It is unclear whether the ... Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.. Authors * Goodfield, M J ... Plasma levels of fibrinogen, von Willebrand factor antigen and factor VIII:C were also measured. Systemic sclerosis was ... Whole blood platelet aggregation was studied in 26 patients with systemic sclerosis, normal subjects matched for age, sex and ...
  https://www.mysciencework.com/publication/show/whole-blood-platelet-aggregation-coagulation-factors-patients-systemic-sclerosis-07739a37
*  تصفح حسب العنوان
A biological standard for measurement of blood coagulation factor VIII activity  Skegg, Joyce L.; Denson, K. W. E.; Brozović, ...
  http://apps.who.int/iris/browse?rpp=20&etal=-1&sort_by=1&type=title&starts_with_previous=C&starts_with=A&order=ASC
*  US5437864A - Method of inhibiting blood coagulation in extracorporeal circulation by inhibiting human tissue factor -...
The method prevents complex formation between tissue factor and factor VII/VIIa and thus inhibits coagulation of blood in ... Anti-tissue factor monoclonal antibodies produced by hybridoma cell lines TFS-5G9 or TF9-6B4 may be used in the claimed methods ... of a therapeutically effective amount of a monoclonal antibody which inhibits the ability of tissue factor to bind to factor ... This invention provides a method of inhibiting coagulation in extracorporeal circulation in a subject, comprising ...
  https://patents.google.com/patent/US5437864?oq=flatulence
*  JoVE Table of Contents: Issue 88, June 2014
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes. Jaimy Miller*1, Daniela Dalm*1, Alexey Y. Koyfman2,3 ... Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport. ... Microfluidic Platform for Measuring Neutrophil Chemotaxis from Unprocessed Whole Blood. Caroline N. Jones*1,2,3, Anh N. Hoang*1 ... Quantifying Single Microvessel Permeability in Isolated Blood-perfused Rat Lung Preparation. Kathirvel Kandasamy1, Kaushik ...
  https://www.jove.com/archive/88/june-2014
*  Patent US9272074 - Surgical fasteners and methods for sealing wounds - Google Patents
... blood coagulation factors; growth factors (e.g., nerve growth factor, insulin-like growth factor); protein inhibitors, protein ... blood clotting factors, hemopoietic factors, interleukins (IL-2, IL-3, IL-4, IL-6), interferons ((3-IFN, (a-IFN and y-IFN), ... colony stimulating factors (e.g., GCSF, GM-CSF, MCSF), insulin, anti-tumor agents and tumor suppressors, blood proteins, ... Inhibition of placenta growth factor (PLGF) mediated metastasis and/or angiogenesis. US20070099251. 17 Oct 2006. 3 May 2007. ...
  http://www.google.ca/patents/US9272074
*  Patent US7524530 - Residual solvent extraction method and microparticles produced thereby - Google Patents
... blood coagulation factors; growth factors (e.g., nerve growth factor, insulin-like growth factor); protein inhibitors, protein ... blood clotting factors, hemopoietic factors, interleukins (IL-2, IL-3, IL-4, IL-6), interferons (β-IFN, α-IFN and γ-IFN), ... erythropoietin, nucleases, tumor necrosis factor, colony stimulating factors (e.g., GCSF, GM-CSF, MCSF), insulin, enzymes (e.g ... superoxide dismutase, tissue plasminogen activator), tumor suppressors, blood proteins, hormones and hormone analogs (e.g., ...
  http://www.google.com/patents/US7524530?dq=6462713
*  Patent US6800663 - Crosslinked hydrogel copolymers - Google Patents
... blood coagulation factors; growth factors (e.g., nerve growth factor, insulin-like growth factor); protein inhibitors, protein ... The blood was collected via syringe without an anticoagulant and transferred to a blood serum separator tubes. The blood was ... blood clotting factors, hemopoietic factors, interleukins (IL-2, IL-3, IL-4, IL-6), interferons (β-IFN, (α-IFN and γ-IFN), ... erythropoietin, nucleases, tumor necrosis factor, colony stimulating factors (e.g., GCSF, GM-CSF, MCSF), insulin, enzymes (e.g ...
  http://www.google.com.au/patents/US6800663
*  'bilayer' Protocols and Video...
Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of ... Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes', 'Visualization of HIV-1 Gag Binding to Giant ... Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes. Jaimy Miller*1, Daniela Dalm*1, Alexey Y. Koyfman2,3 ... Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of ...
  https://www.jove.com/keyword/bilayer
*  'blood coagulation' Protocols and Video...
... blood coagulation' include 'Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes', 'A Microfluidic Flow ... Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay', 'Assessment of the Anticoagulant and ... Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String ... Repeated Blood Collection for Blood Tests in Adult Zebrafish', 'Proliferation and Differentiation of Murine Myeloid Precursor ...
  https://www.jove.com/keyword/blood+coagulation
*  'membrane potentials' Protocols and Video...
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes', 'A Method for Systematic Electrochemical and ... Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells', 'Microprobe Capillary ... Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells', 'A ... Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes. Jaimy Miller*1, Daniela Dalm*1, Alexey Y. Koyfman2,3 ...
  https://www.jove.com/keyword/membrane+potentials?page=8
*  DMOZ - Health: Conditions and Diseases: Blood Disorders: Coagulation Disorders: Factor V Leiden
... is a hereditary blood disorder that causes hypercoagulability and an increased risk of thrombosis. ... Factor V Leiden, also known as Activated Protein C Resistance, ... Support for sufferers of the Factor Five Leiden blood clotting ... Health Conditions and Diseases Blood Disorders Coagulation Disorders Factor V Leiden 2 ... Factor V Leiden, also known as Activated Protein C Resistance, is a hereditary blood disorder that causes hypercoagulability ...
  http://dmoztools.net/Health/Conditions_and_Diseases/Blood_Disorders/Coagulation_Disorders/Factor_V_Leiden/